BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2497686)

  • 1. High-dose TRH treatment of neuromuscular diseases: summary of mechanisms and critique of clinical studies. Summary of section IX.
    Engel WK
    Ann N Y Acad Sci; 1989; 553():462-72. PubMed ID: 2497686
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic trial of intrathecal thyrotropin-releasing hormone (TRH) and a TRH-analogue in amyotrophic lateral sclerosis (ALS).
    Thielen T; Stober T; Schimrigk K
    Adv Exp Med Biol; 1987; 209():305-8. PubMed ID: 3107352
    [No Abstract]   [Full Text] [Related]  

  • 3. TRH and diseases of the motor system.
    Munsat TL; Lechan R; Taft JM; Jackson IM; Reichlin S
    Ann N Y Acad Sci; 1989; 553():388-98. PubMed ID: 2497682
    [No Abstract]   [Full Text] [Related]  

  • 4. Intrathecal thyrotropin-releasing hormone therapy of amyotrophic lateral sclerosis.
    Stober T; Schimrigk K; Dietzsch S; Thielen T
    J Neurol; 1985; 232(1):13-4. PubMed ID: 3923160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRH and amyotrophic lateral sclerosis.
    Griffiths EC
    Neurology; 1987 Jan; 37(1):175-6. PubMed ID: 3099228
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preliminary clinical study on the treatment of amyotrophic lateral sclerosis with TRH].
    Formisano R; Antonini G; Bove R; Millefiorini M; Ruggieri S
    Clin Ter; 1986 Dec; 119(6):479-81. PubMed ID: 3102155
    [No Abstract]   [Full Text] [Related]  

  • 7. Observations on the clinical assessment of patients with motor neuron disease. Experience with a TRH analogue.
    Guiloff RJ; Eckland DJ
    Neurol Clin; 1987 Feb; 5(1):171-92. PubMed ID: 3104752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subacute administration of a TRH analogue (RX77368) in motorneuron disease: an open study.
    Modarres-Sadeghi H; Rogers H; Emami J; Guiloff RJ
    J Neurol Neurosurg Psychiatry; 1988 Sep; 51(9):1146-57. PubMed ID: 3147318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of amyotrophic lateral sclerosis with the TRH analog DN-1417.
    Hawley RJ; Kratz R; Goodman RR; McCutchen CB; Sirdofsky M; Hanson PA
    Neurology; 1987 Apr; 37(4):715-7. PubMed ID: 3104820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin-releasing hormone (TRH) in murine motor neuron disease (the wobbler mouse).
    Kozachuk WE; Mitsumoto H; Salanga VD; Beck GJ; Wilber JF
    J Neurol Sci; 1987 May; 78(3):253-60. PubMed ID: 3108458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of amyotrophic lateral sclerosis with thyrotropin-releasing hormone (TRH).
    Yamane K; Osawa M; Kobayashi I; Maruyama S
    Jpn J Psychiatry Neurol; 1986 Jun; 40(2):179-87. PubMed ID: 3097367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled trial of thyrotropin releasing hormone in amyotrophic lateral sclerosis.
    Brooke MH; Florence JM; Heller SL; Kaiser KK; Phillips D; Gruber A; Babcock D; Miller JP
    Neurology; 1986 Feb; 36(2):146-51. PubMed ID: 3080694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of thyrotropin-releasing hormone therapy in amyotrophic lateral sclerosis. Committee on Health Care Issues, American Neurological Association.
    Ann Neurol; 1987 Oct; 22(4):541-3. PubMed ID: 3124710
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of amyotrophic lateral sclerosis with TRH].
    Klimek A; Szulc-Kuberska J; Czernielewska-Rutkowska I; Głuszcz-Zielińska A
    Neurol Neurochir Pol; 1988; 22(3):206-10. PubMed ID: 3146705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, placebo-controlled trial of TRH in amyotrophic lateral sclerosis.
    Caroscio JT; Cohen JA; Zawodniak J; Takai V; Shapiro A; Blaustein S; Mulvihill MN; Loucas SP; Gudesblatt M; Rube D
    Neurology; 1986 Feb; 36(2):141-5. PubMed ID: 3080693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Note on the use of TRH in amyotrophic lateral sclerosis].
    Serratrice G
    Bull Acad Natl Med; 1985 Oct; 169(7):1013-7. PubMed ID: 3938669
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of amyotrophic lateral sclerosis with thyrotropin releasing hormone].
    Serratrice G; Desnuelle C; Crevat A; Guelton C; Meyer-Dutour A
    Rev Neurol (Paris); 1986; 142(2):133-9. PubMed ID: 3088700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and safety of intravenous and oral administration of a TRH analogue (RX77368) in motor neuron disease.
    Modarres-Sadeghi H; Guiloff RJ
    J Neurol Neurosurg Psychiatry; 1990 Nov; 53(11):944-7. PubMed ID: 2126554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spinal mechanism of the antispastic action of TRH in patients with amyotrophic lateral sclerosis].
    Morin C; Pierrot-Deseilligny E
    Rev Neurol (Paris); 1988; 144(11):701-3. PubMed ID: 3148185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyotrophic lateral sclerosis: effects of acute intravenous and chronic subcutaneous administration of thyrotropin-releasing hormone in controlled trials.
    Mitsumoto H; Salgado ED; Negroski D; Hanson MR; Salanga VD; Wilber JF; Wilbourn AJ; Breuer AC; Leatherman J
    Neurology; 1986 Feb; 36(2):152-9. PubMed ID: 3080695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.